Your browser doesn't support javascript.
loading
[Research on COVID-19 vaccination strategies in Singapore].
Yi, H Y; Zhao, J M; Liang, X F; Ying, Teo Yik.
Afiliação
  • Yi HY; Chinese Preventive Medicine Association, Beijing 100021, China.
  • Zhao JM; Chinese Preventive Medicine Association, Beijing 100021, China.
  • Liang XF; Chinese Preventive Medicine Association, Beijing 100021, China Kangtai Biological Vaccine Industry Research Institute, Jinan University, Guangzhou 510632, China.
  • Ying TY; National University of Singapore, Singapore City 119077, Singapore.
Zhonghua Liu Xing Bing Xue Za Zhi ; 43(3): 310-314, 2022 Mar 10.
Article em Zh | MEDLINE | ID: mdl-35345283
ABSTRACT
As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de saúde: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
...